3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.
Frequently Asked Questions
The market cap of Novelion Therapeutics Inc is N/A
The 52 week high for Novelion Therapeutics Inc is N/A.
The 52 week low for Novelion Therapeutics Inc is N/A.
The PE ratio of Novelion Therapeutics Inc is None.
The price to book ratio of Novelion Therapeutics Inc is None.
Novelion Therapeutics Inc's EBITDA is -15.714.
The 50-day moving average of Novelion Therapeutics Inc is None.
Novelion Therapeutics Inc has None employees.
Current Price | $0.00 |
Prev Close | $0.702 |
Open | $0.00 |
Dividend Yield | N/A |
50-Day Moving Average | N/A |
Beta | N/A |
Avg. Volume | N/A |
PE Ratio | N/A |
52-Week High | N/A |
52-Week Low | N/A |
Market Capitalization | N/A |
EPS | -$5.69 |
Price to Book | N/A |
Revenue Per Employee | N/A |
Enterprise Value/EBITDA | -20.91 |